Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal
Disease Category: Multiple Sclerosis

Trial Information

Are you between the age of 18 and 65 with a diagnosis of Multiple Sclerosis?

The Billings Clinic Research Center is currently conducting a research study to evaluate the safety and tolerability of a once weekly oral dosing of an investigational treatment for patients with Multiple Sclerosis. Qualified participants may receive study-related neurological examinations, physical examinations, laboratory tests, ECG's, MRI's, investigational study medication and compensation for time and travel.

PatientInclusionCriteria
Male/Female between the ages of 18 and 65; diagnosis of clinically isolated syndrome or a relapsing form(s) of Multiple Sclerosis; clinical relapse within the past three years or a gadolinium enhancing lesion on a brain MRI scan within the past 12 months; baseline EDSS score of 0-6.5.

Patient Exclusion Criteria
Primary progressive Multiple Sclerosis; history of malignancy, tuberculosis, invasive fungal infections, herpes zoster infection (or shingles), or other opportunistic infections, or any current active infection; concurrent diagnosis of any other autoimmune disease (i.e., rheumatoid arthritis or lupus).

Marilyn Lindell or Becky Kiesow, Recruitment Team
Billings Clinic Research Center
1045 North 30th Street
Billings, MT 59101
Phone: (406) 255-8470 or toll free at (800) 996-2663
Fax: (406) 255-8479
EMail: research@billingsclinic.org

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.